San Diego, CA (March 31, 2009)-- Novocell, Inc., a stem cell engineering company, today announced that it has received U.S. Patent 7,510,876 with claims covering human definitive endoderm cells, an essential cell for generating not only
pancreatic type cells, which Novocell is developing for use as a cell therapy for diabetes, but also other endoderm lineage - derived tissues and organs such as lungs, intestine, liver, thymus and thyroid.
Not exact matches
CRAC channels are found on many
cell types, including immune
cells and
pancreatic acinar
cells, where aberrant activation of these channels is thought to play a key role in the pathobiology of acute pancreatitis.
Stem
cells have also been identified in human milk, and have the potential to differentiate into mammary epithelial lineages under mammary differentiation conditions in vitro, as well as other
cell types in corresponding microenvironments, including bone
cells, brain
cells, liver
cells,
pancreatic beta
cells and heart
cells.
Since
pancreatic cells are gone, the researchers needed a new
type of
cell to take over the pancreas's job.
Frequent, low - dose chemotherapy regimens avoid this effect and may therefore be more effective at treating certain
types of breast and
pancreatic cancer, according to the murine study «Metronomic chemotherapy prevents therapy - induced stromal activation and induction of tumor - initiating
cells,» which will be published online November 23 in The Journal of Experimental Medicine.
In addition to looking at mouse models of diabetes, the researchers also showed that exposure of human
pancreatic islet
cells — both from healthy donors and from patients with
Type 1 diabetes — to fasting - mimicking diet in a dish stimulated insulin production.
Another
type of white blood
cells — B
cells or B lymphocytes — plays a major role in activating the autoreactive T
cells (T lymphocytes) that then destroy the
pancreatic beta
cells leading to
type 1 diabetes.
Pancreatic neuroendocrine tumors, often referred to as «islet
cell tumors» are a
type of cancer that arises from hormone - releasing
cells in the pancreas.
The team believes that whichever way BMP - 7 is used, it will be less risky than other treatments for
type 1 diabetes that are currently being investigated, such as those that create
pancreatic cells from stem
cells, or by introducing new genes into the body.
We also reactivated insulin production in human
pancreatic cells from
type 1 diabetes patients.»
A protein that helps bones mend also transforms
pancreatic cells into insulin powerhouses — providing hope for a treatment for
type 1 diabetes
«By activating the regeneration of
pancreatic cells, we were able to rescue mice from late - stage
type 1 and
type 2 diabetes.
They've figured out how to turn human stem
cells into functional
pancreatic β
cells — the same
cells that are destroyed by the body's own immune system in
type 1 diabetes patients.
Researchers have used
cells that develop into sperm to create a
type of
pancreatic cell (blue) that secrete insulin (red), which may one day cure
type 1 diabetes in men.
Researchers should be able to cultivate iPS
cells into
cell types they want to study — for example, dopamine neurons in the case of Parkinson's or
pancreatic cells for diabetes — and find out where and how they go wrong.
In humans it could potentially treat
Type 1 diabetes in early stage patients, during what is known as the «honeymoon period,» when the
pancreatic beta
cells have not been completely destroyed and continue to secrete insulin.
«But mounting evidence confirming angiotropism and EVMM has revolutionized the knowledge of how cancer spreads through the body to the point that other scientists have confirmed the process in other solid tumor
cell types such as
pancreatic cancer.»
Transplantation of
pancreatic islets —
cell clusters that contain insulin - producing
cells — prevents severe, potentially life - threatening drops in blood sugar in people with
type 1 diabetes, according to new research.
New clinical trial results show that transplantation of
pancreatic islets —
cell clusters that contain insulin - producing
cells — prevents severe, potentially life - threatening drops in blood sugar in people with
type 1 diabetes.
Protein immunoblot and histochemical analysis with antiserum to
type I NO synthase suggest that the formation of NO in
pancreatic B
cells is catalyzed by an NADPH -(reduced form of nicotinamide adenine dinucleotide phosphate), Ca2 + / calmodulin - dependent
type I NO synthase of about 150 kilodaltons.
It's believed that in
type 1 diabetes, the body's immune system destroys the
pancreatic beta
cells responsible for making insulin, a hormone the body needs to convert food into energy.
Type 1 diabetes is an autoimmune metabolic condition in which the body kills off all the
pancreatic beta
cells that produce the insulin needed for glucose regulation in the body.
Zavazava's team is among several groups aiming to create an alternative source of insulin - producing
pancreatic cells that can be transplanted into patients with
type 1 diabetes.
People with
Type 2 diabetes have an excess of a protein called islet amyloid polypeptide, or IAPP, and the accumulation of this protein is linked to the loss of insulin - producing
pancreatic beta
cells.
In
type 1 diabetes, a person's immune system attacks and destroys the
pancreatic beta
cells that produce insulin.
However, both
types of
pancreatic cells have been extremely difficult to culture in the laboratory.
Dor's own group reports this week that its technique for tracing the origin of circulating DNA detected the expected
type of
cell death in people with
pancreatic cancer,
type 1 diabetes, multiple sclerosis, and brain injuries.
Researchers from Oregon Health and Science University have found that aspirin may slow the spread of some
types of colon and
pancreatic cancer
cells.
Faustman got her idea by chance while transplanting islets, the
pancreatic bodies that contain beta
cells, from normal mice into others that had lost theirs to
type 1, or juvenile, diabetes.
Around 0.4 % of newborns will develop autoimmunity to
pancreatic beta
cells in childhood and receive a diagnosis of
type 1 diabetes before adulthood.
The 5E5 antibody recognized multiple
types of cancer
cells, including leukemia, ovarian, breast, and
pancreatic cancer
cells, but not normal tissues.
This week, he and his colleagues report a potentially significant step toward that goal: a recipe that can turn human stem
cells into functional
pancreatic β
cells — the
cells that are destroyed by the body's own immune system in
type 1 diabetes patients such as Melton's son and daughter.
The combination was significantly toxic to
pancreatic cancer
cells and disrupted tumor growth and extended survival in several
types of advanced
pancreatic cancer mouse models.
In
Type 1 diabetes, the immune system attacks the body, destroying
pancreatic b
cells and preventing the pancreas from producing the insulin.
In the original agreement, WARF gave Geron exclusive rights to develop diagnostic and treatment products in six
types of stem
cell - derived
cell lines:
pancreatic, heart muscle, nerve, blood, bone, and liver.
Furthermore, they integrated single -
cell datasets of
pancreatic tissue from humans and mice, thereby identifying 10
cell types that were shared across species and defining the evolutionary changes occurring in each group.
p85 also is present in insulin - producing
pancreatic beta
cells, and we will also see if changing the level of p85 in beta
cells will make them more resilient when stressed with high insulin demands like those from early
type 2 diabetes.»
Dr. Kulkarni's research focuses on investigating signaling pathways impacting growth and function of
pancreatic islet
cells with the long - term goal of improving therapeutic approaches for the treatment of
type 1 and
type 2 diabetes and obesity - associated conditions.
The PEC - Encap ™ (also known as VC - 01) product candidate is designed to deliver the same
pancreatic progenitor
cells in an immunoprotective device and is currently in active development as a therapy for all patients with
type 1 diabetes as well as insulin requiring patients with
type 2 disease.
In their new Stem
Cells Translational Medicine study they show how this strategy can be safely applied to replace the pancreatic cells lost via autoimmune destruction in type 1 diabetes mellitus (T1D
Cells Translational Medicine study they show how this strategy can be safely applied to replace the
pancreatic cells lost via autoimmune destruction in type 1 diabetes mellitus (T1D
cells lost via autoimmune destruction in
type 1 diabetes mellitus (T1D)[1].
The PEC - Direct ™ product candidate delivers the
pancreatic progenitor
cells in a non-immunoprotective device and is being developed for
type 1 diabetes patients who have severe hypoglycemic episodes, extreme glycemic lability, and / or impaired awareness of hypoglycemia.
Once implanted, the
cells are designed to differentiate into the various
cell types that make up the
pancreatic islet, which could allow for production of insulin and other hormones, such as glucagon, needed to control blood sugar levels.
Using her mouse model, Stromnes watched as
pancreatic tumors developed and noticed that one
type of regulatory immune
cell stood out.
She will be determining the rates and mitochondrial sites of free radical production in
pancreatic beta
cells, something that has not been attempted in any
cell type up to this point.
FOXA1 activation, inducing enhancer reprogramming that endows a cancer
cell with metastatic properties, is an epigenetic mechanism, as opposed to a genetic one, that explains at least one mechanism of metastasis in this form of
pancreatic cancer, and likely, other cancer
types as well.
«The second aim of the study was to see whether
pancreatic insulin and enzyme secretions are controlled by different
types of vagal motoneurons — the
cells of the nervous system that control motor functions of the pancreas through the vagus nerve.»
Pancreatic stellate
cells (PSCs) are the main
cell type causing the desmoplastic reaction.
In addition to iPS
cells derived from progeria - patients, the researchers successfully applied their method to adult mesenchymal stem
cells, which can differentiate into a variety of
cell types, including adipocytes, osteoblasts, chondrocytes, cardiomyocytes, and, as described lately, beta -
pancreatic islets
cells.
New research has uncovered a technique whereby tiny particles mimic the form and function of the body's
pancreatic cells, an approach that is showing promise in halting the onset of
type 1 diabetes.
The patch allows for the same
type of therapy — using
pancreatic cells to regulate insulin — but the
pancreatic cells remain outside the body in the smart patch.